 Arbutus Biopharma Corp, Inc. NASDAQ:ABUS Q1 2022 Earnings Conference Call May 5, 2022 8:45 AM ET Company Participants Lisa Caperelli - VP, IR William Collier - President, CEO Director Michael Sofia - Chief Scientific Officer David Hastings - CFO CAO Gaston Picchio - Chief Development Officer Conference Call Participants Douglas Buchanan - JMP Securities Yuchen Ding - Jefferies Thomas Yip - H.C. Wainwright Co. Luke Herrmann - Robert W. 